Nobuyo Maeda Selected Research

Nobuyo Maeda Research Topics

Disease

41	Atherosclerosis 10/2020 - 02/2002
10	Atherosclerotic Plaque (Atheroma) 01/2017 - 03/2002
10	Inflammation (Inflammations) 01/2016 - 04/2006
9	Hypertension (High Blood Pressure) 07/2015 - 02/2002
8	Insulin Resistance 02/2015 - 07/2004
7	Cardiomegaly (Heart Hypertrophy) 02/2014 - 03/2002
7	Fibrosis (Cirrhosis) 01/2013 - 02/2006
6	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 12/2004
6	Hypertrophy 02/2014 - 06/2003
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 05/2005
5	Body Weight (Weight, Body) 10/2010 - 06/2003
4	Coronary Disease (Coronary Heart Disease) 09/2008 - 12/2002
3	Glomerulonephritis 01/2016 - 10/2002
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2016 - 01/2012
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2014 - 04/2009
3	Lipodystrophy 06/2012 - 11/2009
3	Ascorbic Acid Deficiency (Vitamin C Deficiency) 05/2011 - 03/2002
3	Hypertriglyceridemia 11/2010 - 05/2008
3	Infarction (Infarctions) 10/2010 - 01/2002
3	Hyperlipidemias (Hyperlipidemia) 10/2008 - 08/2004
3	Hypoalphalipoproteinemias (Hypoalphalipoproteinemia) 08/2007 - 05/2005
3	Homocystinuria 08/2007 - 08/2002
3	Hyperhomocysteinemia 08/2007 - 08/2003
3	Infections 10/2006 - 04/2002
2	Pre-Eclampsia (Preeclampsia) 11/2016 - 04/2012
2	Glucose Intolerance 08/2014 - 10/2010
2	Thrombosis (Thrombus) 11/2011 - 08/2003
2	Dyslipidemias (Dyslipidemia) 09/2011 - 11/2009
2	Hyperglycemia 05/2011 - 11/2010
2	Hepatomegaly 11/2010 - 01/2005
2	Rupture 10/2010 - 03/2002
2	Tangier Disease 04/2010 - 05/2005
2	Ureteral Obstruction 04/2009 - 04/2006
2	Vascular Remodeling 04/2009 - 06/2007
2	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 10/2008 - 01/2007
2	Hypercholesterolemia 01/2007 - 09/2005
2	Hyperlipoproteinemia Type III (Broad Beta Disease) 01/2007 - 09/2002
2	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2006 - 04/2006
2	Heart Failure 02/2006 - 04/2005
2	Chronic Granulomatous Disease 10/2004 - 06/2002

Drug/Important Bio-Agent (IBA)

29	ApolipoproteinsIBA 10/2020 - 03/2002
29	Apolipoproteins E (ApoE)IBA 10/2020 - 02/2002
15	CholesterolIBA 01/2014 - 09/2002
11	LipidsIBA 02/2015 - 03/2003
9	Apolipoprotein E4IBA 01/2022 - 01/2004
9	LDL Receptors (LDL Receptor)IBA 09/2011 - 01/2004
9	PPAR gammaIBA 03/2010 - 07/2004
7	AntioxidantsIBA 10/2020 - 03/2002
6	Apolipoprotein E2IBA 01/2022 - 04/2006
6	Proteins (Proteins, Gene)FDA Link 01/2017 - 03/2004
6	CollagenIBA 01/2016 - 03/2002
6	Insulin (Novolin)FDA Link 02/2015 - 11/2009
6	Lipoproteins (Lipoprotein)IBA 02/2013 - 01/2005
5	Apolipoprotein E3IBA 01/2022 - 01/2004
5	lipoic acid synthaseIBA 10/2020 - 08/2010
5	Glucose (Dextrose)FDA LinkGeneric 02/2015 - 07/2004
5	EnzymesIBA 06/2014 - 06/2002
5	Protein Isoforms (Isoforms)IBA 09/2011 - 08/2004
5	Atrial Natriuretic Factor (ANF)IBA 12/2009 - 04/2005
4	LDL Lipoproteins (beta Lipoproteins)IBA 01/2019 - 01/2005
4	LDL CholesterolIBA 01/2019 - 05/2007
4	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2016 - 03/2010
4	Ascorbic Acid (Vitamin C)FDA LinkGeneric 05/2011 - 03/2002
4	Natriuretic PeptidesIBA 12/2009 - 06/2003
4	NF-kappa B (NF-kB)IBA 04/2009 - 10/2006
4	Peroxidase (Myeloperoxidase)IBA 07/2005 - 01/2002
3	AutoantibodiesIBA 01/2016 - 10/2002
3	Matrix Metalloproteinases (MMPs)IBA 01/2016 - 06/2009
3	Rosiglitazone (Avandia)FDA Link 02/2014 - 03/2009
3	Triglycerides (Triacylglycerol)IBA 01/2014 - 05/2008
3	Thioctic Acid (Lipoic Acid)IBA 07/2012 - 08/2006
3	Transcription Factors (Transcription Factor)IBA 05/2011 - 02/2007
3	Messenger RNA (mRNA)IBA 09/2010 - 10/2006
3	oxidized low density lipoproteinIBA 04/2010 - 01/2007
3	atrial natriuretic factor receptor AIBA 04/2009 - 06/2003
3	LigandsIBA 03/2009 - 03/2003
3	Apolipoprotein A-I (Apolipoprotein A1)IBA 08/2007 - 05/2005
3	Cystathionine beta-Synthase (Serine Sulfhydrase)IBA 08/2007 - 08/2003
3	ChemokinesIBA 07/2003 - 04/2002
2	c-Mer Tyrosine KinaseIBA 01/2017 - 01/2015
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2015 - 09/2008
2	Adenosine Triphosphate (ATP)IBA 06/2014 - 03/2004
2	DiureticsIBA 02/2014 - 02/2006
2	Streptozocin (Streptozotocin)FDA Link 07/2012 - 08/2006
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2012 - 08/2007
2	ThiazolidinedionesIBA 10/2010 - 03/2009
2	3' Untranslated Regions (3' UTR)IBA 09/2010 - 05/2007
2	Apolipoproteins B (ApoB)IBA 04/2010 - 10/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2009 - 10/2006
2	Tissue Inhibitor of Metalloproteinase-3IBA 06/2007 - 04/2006
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 10/2006 - 03/2003
2	AldosteroneIBA 02/2006 - 04/2005
2	ReninIBA 02/2006 - 04/2005
2	CCR2 ReceptorsIBA 06/2005 - 03/2003
2	salicylhydroxamic acid (SHAM)IBA 04/2005 - 03/2002
2	NADPH Oxidases (NAD(P)H oxidase)IBA 10/2004 - 06/2002
2	HomocysteineIBA 08/2003 - 08/2002
2	Oxidoreductases (Dehydrogenase)IBA 06/2002 - 03/2002

Therapy/Procedure

3	Therapeutics 06/2014 - 12/2002
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 06/2005 - 03/2003